Interactive: Which countries are receiving COVID-19 vaccines from COVAX?

Our COVID-19 coverage is free. Please consider a Devex Pro subscription to support our journalism.
A health worker fills a syringe with the Pfizer-BioNTech COVID-19 vaccine. Photo by: Lehtikuva / Emmi Korhonen via Reuters

A country-by-country forecast showing the number of vaccine doses countries can expect to receive in the coming months from the COVAX Facility — the global initiative aimed at equitable access to COVID-19 vaccines —  was released this week. The forecast includes data on doses of the Pfizer-BioNTech vaccine expected in the first quarter of this year and doses of the AstraZeneca-University of Oxford expected in the first half of the year.

Devex maps out the projected vaccine allocations, including the type of vaccine each country will receive, and the percentage of its population the doses are expected to reach. Small island developing states such as Nauru, which has a population of about 10,800, appear to be at an advantage as a third of their population will be vaccinated as part of this initial vaccine rollout.


These initial doses are intended to reach 3.3% of the total population of the 145 facility participants that will receive doses within this batch. The aim is to target the most vulnerable populations, including health workers. The African continent, for example, expects to receive 90 million COVID-19 vaccine doses in February.

The Pfizer vaccine was only allocated to 18 countries because of challenges around its need for storage at ultra-cold temperatures, as well as a smaller supply available of this vaccine to the COVAX facility.

These figures are subject to change based on a variety of factors, such as funding, supply volumes, regulatory approval, and country readiness, but are intended to help countries prepare for their vaccine rollouts, giving them insight into which type of vaccine and how many to expect, said Ann Lindstrand, expanded program on immunization coordinator at the World Health Organization, during a press conference.

About the authors

  • Lisa Cornish

    Lisa Cornish is a Senior Reporter based in Canberra, where she focuses on the Australian aid community. Lisa formerly worked with News Corp Australia as a data journalist for the national network and was published throughout Australia in major metropolitan and regional newspapers, including the Daily Telegraph in Melbourne, Herald Sun in Melbourne, Courier-Mail in Brisbane, and online through Lisa additionally consults with Australian government providing data analytics, reporting and visualization services. Lisa was awarded the 2014 Journalist of the Year by the New South Wales Institute of Surveyors.
  • Sara Jerving

    Sara Jerving is a global health reporter based in Nairobi. Her work has appeared in The Wall Street Journal, The New York Times, the Los Angeles Times, Vice News, and Bloomberg News, among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for the Livingston Award for Young Journalists in 2018, part of a Vice News Tonight on HBO team that received an Emmy nomination in 2018 and received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014. She has reported from over a dozen countries.